| Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors AB Zaslavsky, MP Adams, X Cao, T Maj, JE Choi, J Stangl-Kremser, ... Scientific Reports 10 (1), 19296, 2020 | 44 | 2020 |
| Whole-blood transcriptional signatures composed of erythropoietic and NRF2-regulated genes differ between cerebral malaria and severe malarial anemia S Nallandhighal, GS Park, YY Ho, RO Opoka, CC John, TM Tran The Journal of infectious diseases 219 (1), 154-164, 2019 | 28 | 2019 |
| Coxiella burnetii blocks intracellular interleukin-17 signaling in macrophages TM Clemente, M Mulye, AV Justis, S Nallandhighal, TM Tran, SD Gilk Infection and immunity 86 (10), 10.1128/iai. 00532-18, 2018 | 28 | 2018 |
| Biologic significance of magnetic resonance imaging invisibility in localized prostate cancer SS Salami, JB Kaplan, S Nallandhighal, M Takhar, JJ Tosoian, M Lee, ... JCO Precision Oncology 3, 1-12, 2019 | 16 | 2019 |
| The prevalence and density of asymptomatic Plasmodium falciparum infections among children and adults in three communities of western Kenya C Salgado, G Ayodo, MD Macklin, MP Gould, S Nallandhighal, ... Malaria Journal 20, 1-11, 2021 | 13 | 2021 |
| Serial molecular profiling of low-grade prostate cancer to assess tumor upgrading: a longitudinal cohort study SS Salami, JJ Tosoian, S Nallandhighal, TA Jones Jr, S Brockman, ... European urology 79 (4), 456-465, 2021 | 10 | 2021 |
| Development of a whole-urine, multiplexed, next-generation RNA-sequencing assay for early detection of aggressive prostate cancer AK Cani, K Hu, CJ Liu, J Siddiqui, Y Zheng, S Han, S Nallandhighal, ... European Urology Oncology 5 (4), 430-439, 2022 | 9 | 2022 |
| Multigene profiling of circulating tumor cells (CTCs) for prognostic assessment in treatment-naïve metastatic hormone-sensitive prostate cancer (mHSPC) ZR Reichert, T Kasputis, S Nallandhighal, SM Abusamra, A Kasputis, ... International Journal of Molecular Sciences 23 (1), 4, 2021 | 7 | 2021 |
| Molecular characterization of clear cell renal cell carcinoma reveals prognostic significance of epithelial-mesenchymal transition gene expression signature S Nallandhighal, R Vince, R Karim, S Groves, J Stangl-Kremser, ... European Urology Oncology 5 (1), 92-99, 2022 | 5 | 2022 |
| Tumor size and genomic risk in localized prostate cancer C Gaffney, D Liu, V Cooley, X Ma, C Angulo, B Robinson, F Khani, P Cai, ... Urologic Oncology: Seminars and Original Investigations 39 (7), 434. e17-434 …, 2021 | 5 | 2021 |
| Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and … M Farha, S Nallandhighal, R Vince, B Cotta, J Stangl-Kremser, D Triner, ... Cancers 15 (23), 5530, 2023 | 1 | 2023 |
| Prognostic value and therapeutic implications of an integrative molecular subtype and immune content classifier in localized muscle-invasive bladder cancer. M Farha, B Cotta, R Vince, S Nallandhighal, SD Kaffenberger, P Palmbos, ... Journal of Clinical Oncology 40 (6_suppl), 530-530, 2022 | 1 | 2022 |
| MP60-05 MOLECULAR PROFILING OF PROSTATE CANCER REVEALS INCREASED INFLAMMATORY MARKERS AND POOR CLINICAL OUTCOMES IN AFRICAN AMERICAN COMPARED TO EUROPEAN AMERICAN MEN U Singhal, S Nallandhighal, S Bolton, M Farha, J Strangl-Kremser, ... Journal of Urology 206 (Supplement 3), e1042-e1043, 2021 | 1 | 2021 |
| Characterization of the tumor immune microenvironment in clear cell renal cell carcinoma (ccRCC): Prognostic value and therapeutic implications of an M0-macrophage enriched … M Farha, R Vince, S Nallandhighal, J Stangl-Kremser, S Goldenthal, ... Journal of Clinical Oncology 39 (15_suppl), 4572-4572, 2021 | 1 | 2021 |
| PD51-02 INTEGRATIVE MOLECULAR PROFILING OF RENAL CELL CARCINOMA NATIVE TISSUE AND PATIENT DERIVED ORGANOIDS IDENTIFIES PREDICTIVE MARKERS OF DRUG RESPONSE DA Triner, T Pham, S Nallandhighal, B Cotta, Z Knuth, F Sun, A Udager, ... The Journal of Urology 211 (5S), e1064, 2024 | | 2024 |
| Integrative multi-region molecular profiling of primary prostate cancer with synchronous lymph node metastasis to characterize the biologically dominant clone U Singhal, S Nallandhighal, J Tosoian, T Pham, J Stangl-Kremser, CJ Lui, ... | | 2023 |
| Fully automated comprehensive genomic profiling for detection of cancer variants, gene fusions, and complex oncology endpoints GM Lowman, D Cyanam, E Norris, M Toro, C Nemes, T Puranik, Y Zhu, ... Cancer Research 83 (7_Supplement), 232-232, 2023 | | 2023 |
| PD17-11 MOLECULAR PROFILING REVEALS IMMUNOSUPPRESSIVE TUMOR IMMUNE MICROENVIRONMENT IN PRIMARY VERSUS PAIRED ASYNCHRONOUS METASTATIC CLEAR CELL RENAL CELL CARCINOMA B Cotta, S Nallandhighal, D Triner, N Graham, R Mehra, M Cieslik, ... The Journal of Urology 209 (Supplement 4), e500, 2023 | | 2023 |
| Role of adenosine deaminase in prostate cancer progression C Charles, SM Lloyd, DWB Piyarathna, J Gohlke, U Rasaily, V Putluri, ... American Journal of Clinical and Experimental Urology 11 (6), 594, 2023 | | 2023 |
| PD07-06 SPATIAL TRANSCRIPTOMIC PROFILING OF PROSTATE CANCER REVEALS ZONE SPECIFIC ANDROGEN RECEPTOR SIGNALING AND IMMUNE INFILTRATION P Patel, S Nallandhighal, D Scoville, L Tran, B Cotta, A Udager, A Rao, ... The Journal of Urology 207 (Supplement 5), e100, 2022 | | 2022 |
Simpa S. Salami, MD, MPHUniversity of Michigan Medical SchoolVerified email at med.umich.edu
